Doximity rises after Raymond James upgrades to 'strong buy'

Doximity

21/11/2025 18:07

** Shares of telehealth company Doximity  up 8.8% at $50.47

** Raymond James upgrades to "strong buy" from "outperform" rating; PT at $65

** Brokerage sees potential from AI monetization and possible shifts toward direct-to-consumer for healthcare providers, which could support above-market growth

** Sees long-term growth visibility and durability continues to improve

** 11 of 21 brokerages rate the stock "buy" or higher, 10 "hold"; their median PT is $65 - data compiled by LSEG

** As of last close, stock down ~13% YTD

 (Reporting by Sanskriti Shekhar in Bengaluru)

 ((Sanskriti.Shekhar@thomsonreuters.com))